Introduction
Our research focuses on the engineering of novel dermo-epidermal skin substitutes, which: a) can be transplanted in only one surgical intervention (Ref.1 Although significant advances are made in identifying and locating the epithelial stem cell compartment in rodent skin, stem cell data regarding human skin are still vague. We screened a series of antibodies for their exclusive binding to the human hair follicle bulge. In a second step these antibodies were to used to identify basal keratinocytes and potential epithelial stem cells in the human epidermis and in engineered skin substitutes.
Materials and Methods
Human skin samples were taken from the scalp, the abdomen, the retroauricular region, or from foreskins. Organotypic cultures were prepared using a previously established transwell system. Dermo-epidermal skin substitutes were grown and differentiated in vitro after which they were transplanted onto immuno-incompetent rats. Both, in vitro and vivo-grown skin substitutes were analysed by immuno blotting and immunofluorescence techniques.
Results
We showed that cytokeratin 19-expressing keratinocytes are a subpopulation of cytokeratin 15-positive basal keratinocytes in the epidermal stratum basale of normal skin. Notably, cytokeratin 19/15-double-positive keratinocytes are no longer detectable in children older than two years. 
Discussion and Conclusions
Cytokeratin 19-expressing keratinocytes represent a subpopulation of basal keratinocytes in neonates, young children (up to 1.5 years) and in engineered skin grafts. K19/K15-doublepositive keratinocytes represent a distinct basalcell population in growing skin. For engineered skin substitutes K19 and K15 in combination are valuable tools to monitor tissue homeostasis and the potential to self-renew.
